Cite
HARVARD Citation
Bhuyan, P. et al. (2021). Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL. Human vaccines & immunotherapeutics. 17 (5), pp. 1288-1293. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bhuyan, P. et al. (2021). Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL. Human vaccines & immunotherapeutics. 17 (5), pp. 1288-1293. [Online].